1 / 10

The Medical Device Pathway as a Legal Onramp for Futuristic Persons

Terasem. THE FUTURE. The Medical Device Pathway as a Legal Onramp for Futuristic Persons. The Medical Device Pathway as a Legal Onramp for Futuristic Persons. Martine Rothblatt Terasem’s 6 th Annual Colloquium On the Law of Futuristic Persons. The FDA rules pertaining to medical devices.

Download Presentation

The Medical Device Pathway as a Legal Onramp for Futuristic Persons

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Terasem THE FUTURE The Medical Device Pathway as a Legal Onramp for Futuristic Persons The Medical Device Pathway as a Legal Onramp for Futuristic Persons Martine Rothblatt Terasem’s 6th Annual Colloquium On the Law of Futuristic Persons martine4@gmail.com

  2. The FDA rules pertaining to medical devices • As found within the Code of Federal regulations at: 21 CFR 800 to 1299 • and within the Center for Devices and Radiological Health (CDRH) • division of the FDA responsible for medical device regulation; • When distributed in the United Sates, subject to General Controls, • pre-marketing and post marketing regulatory controls include: • A) Establishment Registration by manufacturers, distributors, repackages • and re-labelers; • B) Medical Device Listing with FDA of devices to be marketed; • C) Manufacturing the devices in accordance with Good Manufacturing • Practices; • D) Labeling medical devices in accordance with the labeling regulations, • 21 CFR 801 or 21 CFR 809; and • E) Medical Device Reporting of adverse events as identified by the user, • manufacturer and/or distributor of the medial device. 3 12/10/10 Martine4@gmail.com

  3. To what extent are medical nanobots medical devices? http://kentonspi.blogspot.com/2008/04/nano-technology-nanomagnet-system-could.html • Section 201(h) defines a medical device as "an instrument, apparatus, implement, machine, contrivance…intended for use in the … cure, mitigation, treatment, or prevention of disease, in man or other animals… and which is not dependent upon being metabolized for the achievement of any of its primary intended purposes.” Nanorobots the bloodstream Martine4@gmail.com

  4. FDA medical device classification • There are 3 FDA regulatory classifications of medical devices: Class I, Class II and Class III, assigned by the risk the medical device presents to the patient and the level of regulatory control the FDA determines is needed to legally market the device. • The FDA classification of medical devices is based upon classifications for devices currently legally marketed in the United States. • New medical devices are compared to legally marketed medical device classifications with the same intended use and technological characteristics to determine the device classification. Martine4@gmail.com 4 12/10/10

  5. CFR medical device classification • Class I medical devices have the least amount of regulatory control, • present minimal potential harm to the user, are typically simple in • design manufacture and have a history of safe use. • Class II devices typically require pre-market notification by • submission and FDA review of a 510(k)* clearance to market • submission. • Class III devices usually support or sustain human life, are of • substantial importance in preventing impairment of human health, • or present a potential unreasonable risk of illness or injury to the • patient and require a Pre-Market Approval (PMA) submission to • the FDA prior to marketing. 12/10/10 Martine4@gmail.com 5

  6. Medical Devices http://www.reference.com/browse/x-ray http://unimaxsupply.com/md/1tong.htm Class l Medical Device Low risk to patient Class ll Medical Devices Medium risk to patient High risk to patient http://emedicine.medscape.com/article/1681045-overview http://healthguide.howstuffworks.com/heart-valve-surgery-picture.htm Class III Medical Device Implanted nerve stimulator Class III Medical Device Synthetic heart valves Martine4@gmail.com

  7. What FDA Requirement would pertain to medical nanobots used on a legally dead ? • If the nanobot revived the human body, then the body would be alive in which case it would be a medical device.  • The nanobot would not be able to go through 510(k) since it is a novel technology and there are no available predicates.  • The nanobot would likely be a PMA device, which would require a clinical study to demonstrate safety and effectiveness. Martine4@gmail.com

  8. Is a robot into which a biological mind has been digitized and uploaded a medical device? • A robot, such as the Bina48, would not be considered a medical device because it is not used in or on the human body. • Very similar to computer modeling, i.e. creating a simulated environment that mimics the human body/mind and that can be used to validate the functions of devices on the human body/mind.  • Such computer models are not regulated by the FDA.  • But, if the model were to be used for testing of devices that would be used on humans in the future, it would be beneficial to have the model validated by the FDA for such use.  BINA48 Martine4@gmail.com

  9. What rules to ensure that uploaded minds running on medical devices are safe and effective and not inhumane, tortuous, painful or inaccurate? • The question of whether the device is "inhumane, tortuous, painful or inaccurate" would be established through progressive clinical trials and investigational review board (IRB) approvals.  • The endpoints to be measured and the protocol for such trials would be established in advance through a pre-IDE meetings with FDA or similar and meetings with IRBs and professional groups.  Martine4@gmail.com

  10. Thank you Martine4@gmail.com

More Related